Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer (npj Breast Cancer, (2021), 7, 1, (9), 10.1038/s41523-021-00219-7)

Julia Foldi; Andrea Silber; Emily Reisenbichler; Kamaljeet Singh; Neal Fischbach; Justin Persico; Kerin Adelson; Anamika Katoch; Nina Horowitz; Donald Lannin; Anees Chagpar; Tristen Park; Michal Marczyk; Courtney Frederick; Trisha Burrello; Eiman Ibrahim; Tao Qing; Yalai Bai; Kim Blenman; David L. Rimm; Lajos Pusztai

doi:10.1038/s41523-022-00392-3

Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer (npj Breast Cancer, (2021), 7, 1, (9), 10.1038/s41523-021-00219-7)

Julia Foldi
, Andrea Silber
, Emily Reisenbichler
, Kamaljeet Singh
, Neal Fischbach
, Justin Persico
, Kerin Adelson
, Anamika Katoch
, Nina Horowitz
, Donald Lannin
, Anees Chagpar
, Tristen Park
, Michal Marczyk
, Courtney Frederick
, Trisha Burrello
, Eiman Ibrahim
, Tao Qing
, Yalai Bai
, Kim Blenman
, David L. Rimm

Lajos Pusztai

Department of Data Science and Engineering (RAU/RAU4)

Yale University

Research output: Contribution to journal › Comment/debate

4 Citations (Scopus)

Abstract

The original version of the published Article had an error in the Author affiliations. The second affiliation for co-Author Michal Marczyk was inadvertently omitted. The following affiliation has been added: Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland. The HTML and PDF versions of the Article have been corrected.

Original language	English
Article number	17
Journal	npj Breast Cancer
Volume	8
Issue number	1
DOIs	https://doi.org/10.1038/s41523-022-00392-3
Publication status	Published - Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology
Radiology, Nuclear Medicine and Imaging
Pharmacology (medical)

Access to Document

10.1038/s41523-022-00392-3

Fingerprint

Dive into the research topics of 'Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer (npj Breast Cancer, (2021), 7, 1, (9), 10.1038/s41523-021-00219-7)'. Together they form a unique fingerprint.

Cite this

Foldi, J., Silber, A., Reisenbichler, E., Singh, K., Fischbach, N., Persico, J., Adelson, K., Katoch, A., Horowitz, N., Lannin, D., Chagpar, A., Park, T., Marczyk, M., Frederick, C., Burrello, T., Ibrahim, E., Qing, T., Bai, Y., Blenman, K., ... Pusztai, L. (2022). Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer (npj Breast Cancer, (2021), 7, 1, (9), 10.1038/s41523-021-00219-7). npj Breast Cancer, 8(1), Article 17. https://doi.org/10.1038/s41523-022-00392-3

@article{969a6b8b1792456081707650d217d73a,

title = "Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer (npj Breast Cancer, (2021), 7, 1, (9), 10.1038/s41523-021-00219-7)",

abstract = "The original version of the published Article had an error in the Author affiliations. The second affiliation for co-Author Michal Marczyk was inadvertently omitted. The following affiliation has been added: Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland. The HTML and PDF versions of the Article have been corrected.",

author = "Julia Foldi and Andrea Silber and Emily Reisenbichler and Kamaljeet Singh and Neal Fischbach and Justin Persico and Kerin Adelson and Anamika Katoch and Nina Horowitz and Donald Lannin and Anees Chagpar and Tristen Park and Michal Marczyk and Courtney Frederick and Trisha Burrello and Eiman Ibrahim and Tao Qing and Yalai Bai and Kim Blenman and Rimm, \{David L.\} and Lajos Pusztai",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = dec,

doi = "10.1038/s41523-022-00392-3",

language = "English",

volume = "8",

journal = "npj Breast Cancer",

issn = "2374-4677",

publisher = "Nature Research",

number = "1",

}

Foldi, J, Silber, A, Reisenbichler, E, Singh, K, Fischbach, N, Persico, J, Adelson, K, Katoch, A, Horowitz, N, Lannin, D, Chagpar, A, Park, T, Marczyk, M, Frederick, C, Burrello, T, Ibrahim, E, Qing, T, Bai, Y, Blenman, K, Rimm, DL & Pusztai, L 2022, 'Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer (npj Breast Cancer, (2021), 7, 1, (9), 10.1038/s41523-021-00219-7)', npj Breast Cancer, vol. 8, no. 1, 17. https://doi.org/10.1038/s41523-022-00392-3

Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer (npj Breast Cancer, (2021), 7, 1, (9), 10.1038/s41523-021-00219-7). / Foldi, Julia; Silber, Andrea; Reisenbichler, Emily et al.
In: npj Breast Cancer, Vol. 8, No. 1, 17, 12.2022.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Author Correction

T2 - Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer (npj Breast Cancer, (2021), 7, 1, (9), 10.1038/s41523-021-00219-7)

AU - Foldi, Julia

AU - Silber, Andrea

AU - Reisenbichler, Emily

AU - Singh, Kamaljeet

AU - Fischbach, Neal

AU - Persico, Justin

AU - Adelson, Kerin

AU - Katoch, Anamika

AU - Horowitz, Nina

AU - Lannin, Donald

AU - Chagpar, Anees

AU - Park, Tristen

AU - Marczyk, Michal

AU - Frederick, Courtney

AU - Burrello, Trisha

AU - Ibrahim, Eiman

AU - Qing, Tao

AU - Bai, Yalai

AU - Blenman, Kim

AU - Rimm, David L.

AU - Pusztai, Lajos

PY - 2022/12

Y1 - 2022/12

N2 - The original version of the published Article had an error in the Author affiliations. The second affiliation for co-Author Michal Marczyk was inadvertently omitted. The following affiliation has been added: Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland. The HTML and PDF versions of the Article have been corrected.

AB - The original version of the published Article had an error in the Author affiliations. The second affiliation for co-Author Michal Marczyk was inadvertently omitted. The following affiliation has been added: Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland. The HTML and PDF versions of the Article have been corrected.

UR - https://www.scopus.com/pages/publications/85124396640

U2 - 10.1038/s41523-022-00392-3

DO - 10.1038/s41523-022-00392-3

M3 - Comment/debate

AN - SCOPUS:85124396640

SN - 2374-4677

VL - 8

JO - npj Breast Cancer

JF - npj Breast Cancer

IS - 1

M1 - 17

ER -

Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer (npj Breast Cancer, (2021), 7, 1, (9), 10.1038/s41523-021-00219-7)

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this